Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,175,662 | $2,000,843 | $1,689,041 | $2,242,889 |
| Short-Term Investments | $886,810 | $1,101,059 | $868,417 | $836,796 |
| Receivables | $1,497,952 | $1,482,232 | $1,277,844 | $1,301,778 |
| Inventory | $4,670,336 | $4,952,734 | $5,393,947 | $5,612,822 |
| Other Curr. Assets | $283,452 | $337,076 | $392,025 | $377,698 |
| Total Curr. Assets | $9,514,212 | $9,873,944 | $9,621,274 | $10,371,983 |
| Property Plant & Equip (Net) | $2,594,877 | $2,622,871 | $2,647,675 | $2,633,169 |
| Goodwill | $2,347,262 | $2,353,689 | $2,357,034 | $2,297,685 |
| Intangibles | $376,876 | $391,829 | $405,515 | $449,719 |
| Long-Term Investments | $0 | $715,803 | $955,076 | $1,044,119 |
| Tax Assets | $317,468 | $283,621 | $282,510 | $271,152 |
| Other NC Assets | $2,084,277 | $1,304,044 | $1,074,440 | $1,053,591 |
| Total NC Assets | $7,720,761 | $7,671,858 | $7,722,250 | $7,749,435 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17,234,973 | $17,545,802 | $17,343,524 | $18,121,417 |
| Liabilities | – | – | – | – |
| Payables | $364,792 | $316,197 | $299,692 | $343,998 |
| Short-Term Debt | $1,801,106 | $1,819,532 | $1,838,944 | $1,943,995 |
| Tax Payable | $181,742 | $213,485 | $153,508 | $217,576 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,807,414 | $1,524,753 | $1,407,093 | $1,835,723 |
| Total Curr. Liab. | $4,155,054 | $3,873,968 | $3,699,237 | $4,341,292 |
| LT Debt | $569,005 | $1,029,265 | $1,138,818 | $1,256,266 |
| Deferred Rev, NC | $44,545 | $45,280 | $27,285 | $27,207 |
| Deferred Tax Liab, NC | $226,860 | $223,989 | $242,494 | $239,575 |
| Other NC Liab. | $27,539 | $33,264 | $33,569 | $42,550 |
| Total NC Liab. | $867,947 | $1,331,799 | $1,442,166 | $1,565,597 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $40,833 | $49,375 | $57,770 | $63,723 |
| Total Liabilities | $5,023,001 | $5,205,766 | $5,141,403 | $5,906,889 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,467,296 | $1,467,296 | $1,467,296 | $1,467,296 |
| Retained Earnings | $4,087,714 | $4,189,278 | $4,032,688 | $4,166,060 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $6,604,197 | $6,630,439 | $6,648,689 | $6,507,029 |
| Total Equity | $12,159,208 | $12,287,013 | $12,148,673 | $12,140,385 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $52,765 | $53,023 | $53,448 | $74,144 |
| Total Liab. & Tot. Equity | $17,234,973 | $17,545,802 | $17,343,524 | $18,121,417 |
| Net Debt | $194,449 | $847,954 | $1,288,721 | $957,372 |